Ausgabe 6/2018
Inhalt (11 Artikel)
Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
R. J. de Winter
Optimal treatment of patients with NSTE-ACS in the Dutch health care system
J. P. van Kuijk, J. M. ten Berg
Optimal pharmacological therapy in ST-elevation myocardial infarction—a review
R. S. Hermanides, S. Kilic, A. W. J. van ’t Hof
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
R. Pisters, A. Elvan, H. J. G. M. Crijns, M. E. W. Hemels
Optimal duration of dual antiplatelet therapy for coronary artery disease
W. J. Kikkert, P. Damman
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
M. S. Jacobs, R. G. Tieleman
A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment
M. E. Gimbel, S. C. S. Minderhoud, J. M. ten Berg
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
S. P. G. van Vugt, M. A. Brouwer
Delayed neointimal healing pattern after bioresorbable scaffold implantation
D. Ochijewicz, M. Tomaniak, J. Kochman, L. Koltowski, A. Rdzanek, A. Pietrasik, G. Opolski